Genolution Inc. (KOSDAQ:225220)

South Korea · Delayed Price · Currency is KRW

1,733.00

+33.00 (1.94%)

At close: Nov 12, 2026

Market Cap	31.31B -20.5%
Revenue (ttm)	10.03B +14.4%
Net Income	-4.66B
EPS	-257.91
Shares Out	18.07M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,348
Open	1,657.00
Previous Close	1,700.00
Day's Range	1,657.00 - 1,740.00
52-Week Range	957.00 - 2,255.00
Beta	0.06
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Genolution

Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology. The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/RNA extraction kits. It also develops and manufactures instruments and reagents for DNA/RNA; provides long dsRNA synthesis services; and siRNA/miRNA/sh... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2006

Employees 72

Stock Exchange KOSDAQ

Ticker Symbol 225220

Full Company Profile

Financial Performance

In 2025, Genolution's revenue was 9.40 billion, an increase of 31.79% compared to the previous year's 7.14 billion. Losses were -11.64 billion, 70.6% more than in 2024.

Financial Statements